Literature DB >> 30707393

Upregulation of Proteolytic Pathways and Altered Protein Biosynthesis Underlie Retinal Pathology in a Mouse Model of Alzheimer's Disease.

Mehdi Mirzaei1,2,3, Kanishka Pushpitha4, Liting Deng5, Nitin Chitranshi4, Veer Gupta6, Rashi Rajput4, Abu Bakr Mangani4, Yogita Dheer4, Angela Godinez4, Matthew J McKay5,7, Karthik Kamath5,7, Dana Pascovici5,7, Jemma X Wu5,7, Ghasem Hosseini Salekdeh5,8, Tim Karl9, Paul A Haynes5, Stuart L Graham4, Vivek K Gupta10.   

Abstract

Increased amyloid β (Aβ) aggregation is a hallmark feature of Alzheimer's disease (AD) pathology. The APP/PS1 mouse model of AD exhibits accumulation of Aβ in the retina and demonstrates reduced retinal function and other degenerative changes. The overall molecular effects of AD pathology on the retina remain undetermined. Using a proteomics approach, this study assessed the molecular effects of Aβ accumulation and progression of AD pathology on the retina. Retinal tissues from younger (2.5 months) and older 8-month APP/PS1 mice were analysed for protein expression changes. A multiplexed proteomics approach using chemical isobaric tandem mass tags was applied followed by functional and protein-protein interaction analyses using Ingenuity pathway (IPA) and STRING computational tools. We identified approximately 2000 proteins each in the younger (upregulated 50; downregulated 36) and older set of APP/PS1 (upregulated 85; downregulated 79) mice retinas. Amyloid precursor protein (APP) was consistently upregulated two to threefold in both younger and older retinas (p < 0.0001). Mass spectrometry data further revealed that older APP/PS1 mice retinas had elevated levels of proteolytic enzymes cathepsin D, presenilin 2 and nicastrin that are associated with APP processing. Increased levels of proteasomal proteins Psma5, Psmd3 and Psmb2 were also observed in the older AD retinas. In contrast to the younger animals, significant downregulation of protein synthesis and elongation associated proteins such as Eef1a1, Rpl35a, Mrpl2 and Eef1e1 (p < 0.04) was identified in the older mice retinas. This study reports for the first time that not only old but also young APP/PS1 animals demonstrate increased amyloid protein levels in their retinas. Quantitative proteomics reveals new molecular insights which may represent a cellular response to clear amyloid build-up. Further, downregulation of ribosomal proteins involved in protein biosynthesis was observed which might be considered a toxicity effect.

Entities:  

Keywords:  APP/PS1; Alzheimer's disease; Amyloid beta; Quantitative proteomics; Retina; Tandem mass tag

Mesh:

Substances:

Year:  2019        PMID: 30707393     DOI: 10.1007/s12035-019-1479-4

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  71 in total

1.  Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach.

Authors:  Rukhsana Sultana; H Fai Poon; Jian Cai; William M Pierce; Michael Merchant; Jon B Klein; William R Markesbery; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2005-12-27       Impact factor: 5.996

2.  The relationship between alphaB-crystallin and neurofibrillary tangles in Alzheimer's disease.

Authors:  J J Mao; S Katayama; C Watanabe; Y Harada; K Noda; Y Yamamura; S Nakamura
Journal:  Neuropathol Appl Neurobiol       Date:  2001-06       Impact factor: 8.090

3.  Inhibition of cathepsin B reduces beta-amyloid production in regulated secretory vesicles of neuronal chromaffin cells: evidence for cathepsin B as a candidate beta-secretase of Alzheimer's disease.

Authors:  Vivian Hook; Thomas Toneff; Matthew Bogyo; Doron Greenbaum; Katalin F Medzihradszky; John Neveu; William Lane; Gregory Hook; Terry Reisine
Journal:  Biol Chem       Date:  2005-09       Impact factor: 3.915

4.  The plasmin system is induced by and degrades amyloid-beta aggregates.

Authors:  H M Tucker; M Kihiko; J N Caldwell; S Wright; T Kawarabayashi; D Price; D Walker; S Scheff; J P McGillis; R E Rydel; S Estus
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

5.  Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology.

Authors:  Rebecca Radde; Tristan Bolmont; Stephan A Kaeser; Janaky Coomaraswamy; Dennis Lindau; Lars Stoltze; Michael E Calhoun; Fabienne Jäggi; Hartwig Wolburg; Simon Gengler; Christian Haass; Bernardino Ghetti; Christian Czech; Christian Hölscher; Paul M Mathews; Mathias Jucker
Journal:  EMBO Rep       Date:  2006-08-11       Impact factor: 8.807

6.  Elongation of axons during regeneration involves retinal crystallin beta b2 (crybb2).

Authors:  Thomas Liedtke; Jens Christian Schwamborn; Uwe Schröer; Solon Thanos
Journal:  Mol Cell Proteomics       Date:  2007-01-29       Impact factor: 5.911

7.  Amyloid-beta-stimulated plasminogen activation by tissue-type plasminogen activator results in processing of neuroendocrine factors.

Authors:  O Kranenburg; Y Y J Gent; E P Romijn; E E Voest; A J R Heck; M F B G Gebbink
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

8.  Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease.

Authors:  Susi Keck; Robert Nitsch; Tilman Grune; Oliver Ullrich
Journal:  J Neurochem       Date:  2003-04       Impact factor: 5.372

9.  Retinal abnormalities in early Alzheimer's disease.

Authors:  Fatmire Berisha; Gilbert T Feke; Clement L Trempe; J Wallace McMeel; Charles L Schepens
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-05       Impact factor: 4.799

10.  Ribosome dysfunction is an early event in Alzheimer's disease.

Authors:  Qunxing Ding; William R Markesbery; Qinghua Chen; Feng Li; Jeffrey N Keller
Journal:  J Neurosci       Date:  2005-10-05       Impact factor: 6.709

View more
  11 in total

1.  Visual-stimuli Four-arm Maze test to Assess Cognition and Vision in Mice.

Authors:  Jean-Philippe Vit; Dieu-Trang Fuchs; Ariel Angel; Aharon Levy; Itschak Lamensdorf; Keith L Black; Yosef Koronyo; Maya Koronyo-Hamaoui
Journal:  Bio Protoc       Date:  2021-11-20

Review 2.  Roles of aminoacyl-tRNA synthetase-interacting multi-functional proteins in physiology and cancer.

Authors:  Zheng Zhou; Bao Sun; Shiqiong Huang; Dongsheng Yu; Xiaochuan Zhang
Journal:  Cell Death Dis       Date:  2020-07-24       Impact factor: 8.469

3.  Complement pathway in Alzheimer's pathology and retinal neurodegenerative disorders - the road ahead.

Authors:  Mehdi Mirzaei; Liting Deng; Veer Bala Gupta; Stuart Graham; Vivek Gupta
Journal:  Neural Regen Res       Date:  2020-02       Impact factor: 5.135

4.  Meta-Analysis of Gene Expression Changes in the Blood of Patients with Mild Cognitive Impairment and Alzheimer's Disease Dementia.

Authors:  Virginie Bottero; Judith A Potashkin
Journal:  Int J Mol Sci       Date:  2019-10-30       Impact factor: 5.923

Review 5.  Abnormal Expression of Mitochondrial Ribosomal Proteins and Their Encoding Genes with Cell Apoptosis and Diseases.

Authors:  Guomin Huang; Hongyan Li; Hong Zhang
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

Review 6.  Role of Retinal Amyloid-β in Neurodegenerative Diseases: Overlapping Mechanisms and Emerging Clinical Applications.

Authors:  Liang Wang; Xiaobo Mao
Journal:  Int J Mol Sci       Date:  2021-02-26       Impact factor: 5.923

7.  Inner retinal injury in experimental glaucoma is prevented upon AAV mediated Shp2 silencing in a caveolin dependent manner.

Authors:  Mojdeh Abbasi; Vivek K Gupta; Nitin Chitranshi; Veer Gupta; Reza Ranjbaran; Rashi Rajput; Kanishka Pushpitha; Devaraj Kb; Yuyi You; Ghasem Hosseini Salekdeh; Robert G Parton; Mehdi Mirzaei; Stuart L Graham
Journal:  Theranostics       Date:  2021-04-15       Impact factor: 11.556

Review 8.  A Proteomic View of Cellular and Molecular Effects of Cannabis.

Authors:  Morteza Abyadeh; Vivek Gupta; Joao A Paulo; Veer Gupta; Nitin Chitranshi; Angela Godinez; Danit Saks; Mafruha Hasan; Ardeshir Amirkhani; Matthew McKay; Ghasem H Salekdeh; Paul A Haynes; Stuart L Graham; Mehdi Mirzaei
Journal:  Biomolecules       Date:  2021-09-27

Review 9.  Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer's Disease.

Authors:  Morteza Abyadeh; Vivek Gupta; Veer Gupta; Nitin Chitranshi; Yunqi Wu; Ardeshir Amirkhani; Anna Meyfour; Samran Sheriff; Ting Shen; Kunal Dhiman; H Salekdeh Ghasem; A Haynes Paul; L Graham Stuart; Mehdi Mirzaei
Journal:  Aging Dis       Date:  2021-12-01       Impact factor: 6.745

10.  The Dynamic Proteome of Oligodendrocyte Lineage Differentiation Features Planar Cell Polarity and Macroautophagy Pathways.

Authors:  Paria Pooyan; Razieh Karamzadeh; Mehdi Mirzaei; Anna Meyfour; Ardeshir Amirkhan; Yunqi Wu; Vivek Gupta; Hossein Baharvand; Mohammad Javan; Ghasem Hosseini Salekdeh
Journal:  Gigascience       Date:  2020-10-31       Impact factor: 6.524

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.